SYNLAB - HEALTH FOR YOU LIMITED
Get an alert when SYNLAB - HEALTH FOR YOU LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-04-03 (in 11mo)
Last made up 2026-03-20
Watchouts
Cash
£147K
-66.3% vs 2023
Net assets
-£449K
+96.5% vs 2023
Employees
11
+22.2% vs 2023
Profit before tax
-£7M
+23.3% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
On 3 December 2024, Synlab AG, the ultimate parent company, determined that maintaining Synlab Health For You Ltd in its current form is no longer aligned with its strategic objectives. As a result, the financial statements for the year ended 31 December 2024 have not been prepared on a going concern basis. As the Company has transferred the intangible asset to the Group Company and ceased the operations, directors will look to place the Company into liquidation.
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £1,000 | — | |
| Operating profit | -£8,365,000 | -£5,447,000 | |
| Profit before tax | -£8,507,000 | -£6,527,000 | |
| Net profit | -£8,507,000 | -£6,527,000 | |
| Cash | £436,000 | £147,000 | |
| Total assets less current liabilities | -£12,922,000 | -£449,000 | |
| Net assets | -£12,922,000 | -£449,000 | |
| Equity | -£12,922,000 | -£449,000 | |
| Average employees | 9 | 11 | |
| Wages | £785,000 | £1,694,000 | |
| Directors' remuneration | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
-66.3%
£436,000 £147,000
-
Net assets
+96.5%
-£12,922,000 -£449,000
-
Employees
+22.2%
9 11
-
Operating profit
+34.9%
-£8,365,000 -£5,447,000
-
Profit before tax
+23.3%
-£8,507,000 -£6,527,000
-
Wages
+115.8%
£785,000 £1,694,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 64.7% | 1213.1% | |
| Gearing (liabilities / total assets) | 2034.4% | 281.0% | |
| Current ratio | 0.05x | 0.36x | |
| Interest cover | -58.91x | -5.04x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“On 3 December 2024, Synlab AG, the ultimate parent company, determined that maintaining Synlab Health For You Ltd in its current form is no longer aligned with its strategic objectives. As a result, the financial statements for the year ended 31 December 2024 have not been prepared on a going concern basis. As the Company has transferred the intangible asset to the Group Company and ceased the operations, directors will look to place the Company into liquidation.”
Significant events
- “Due to a strategic decision made on 3 December 2024, the Company ceased trading during financial year 2025 and the intangible asset was transferred to Synlab Services S.L in September 2025.”
- “the Directors note that the Company is expected to enter formal liquidation proceedings during the 2025 financial year”
- “In September, 2025 the Company ceased trading activities including developing its web platform and the platform has been transferred to Synlab Services S.L., another Group Company.”
- “On 3 December 2024, Synlab AG, the ultimate parent company, determined that maintaining Synlab Health For You Ltd in its current form is no longer aligned with its strategic objectives.”
- “During the reporting period, Synlab Bondco PLC, the lender, resolved to write off an intercompany loan amounting to £19 million issued to the Company.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 2 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| EVANS, Thomas Edward | Director | 2022-03-22 | May 1980 | British |
| KÖPNICK, Benedikt | Director | 2022-05-04 | Aug 1987 | German |
Show 2 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| STEINWANDER, Robert | Director | 2022-03-22 | 2022-11-28 |
| VASSILIOU, Pavlos | Director | 2022-11-28 | 2024-12-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Synlab Ag | Corporate entity | Shares 75–100%, Voting 75–100% | 2022-03-22 | Active |
Filing timeline
Last 16 of 16 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-04 | AA | accounts | Accounts with accounts type full | |
| 2025-07-04 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-13 | AA | accounts | Accounts with accounts type full | |
| 2024-03-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-27 | AA | accounts | Accounts with accounts type full | |
| 2024-01-02 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-12-21 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-05-25 | CH01 | officers | Change person director company with change date | |
| 2023-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-28 | AP01 | officers | Appoint person director company with name date | |
| 2022-11-28 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-23 | AA01 | accounts | Change account reference date company current shortened | |
| 2022-05-05 | AP01 | officers | Appoint person director company with name date | |
| 2022-03-22 | NEWINC | incorporation | Incorporation company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.